findmyKOL

Jonathan Davidorf, MD

Basic profile

Davidorf Eye Group

ORCIDNPI
RegionWest Hills, CA · WestSpecialtyOphthalmologyFocusOphthalmology
Last active 2020findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Jonathan Davidorf is an Ophthalmology physician affiliated with Davidorf Eye Group. OpenAlex indexes 36 publications with 1,241 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
36publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,241citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

4 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    67.7%
    Prostaglandin Analog27.7%
    Latanoprost92%Lumigan8%
    Part D182 patients
    Corticosteroid11%
    Prednisolone Acetate100%
    Part D145 patients

    + 8 more classes in this area

  • Musculoskeletal

    14.3%
    Cyclooxygenase Inhibitor14.3%
    Ketorolac Tromethamine100%
    Part D229 patients
  • Cardiovascular

    10.5%
    Beta blocker10.5%
    Timolol Maleate100%
    Part D103 patients
Where care is delivered (Part B)7.2% facility · 92.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

31 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”